Skip to content

Richmont publishes research and market information only. We do not sell, supply or broker any peptide or compound. Read our scope

RichmontConsultants

Independent research and market intelligence on peptides

Evidence reviews, market reports and regulatory briefings for people who need to understand the peptide field properly. Every claim is referenced, every edition is dated, and no supplier pays to be included.

GLP-1 (7–37), the 31-residue incretin hormone covered in our incretin evidence review, coloured by residue class.HydrophobicPolarPositively chargedNegatively charged

What we publish, and what we don't

Richmont is a research publisher. Our packs help you understand a field: what has been studied, what the market looks like and how it is regulated. They are not a route to obtaining or using any substance.

Every pack gives you

  • Literature reviews referenced to primary, peer-reviewed sources
  • Market sizing, channel structure and pricing benchmarks
  • Regulatory summaries for the UK, EU and US
  • A dated edition with a change log and a downloadable reference library

We never

  • Sell, supply, source or broker any peptide or compound
  • Give dosing, administration or usage protocols for people or animals
  • Provide medical advice or recommend any treatment
  • Accept payment from suppliers to feature, rank or recommend them

Featured packs

Each pack is a self-contained PDF report with a reference library. Research packs review the published evidence; market packs cover suppliers, channels, pricing and regulation.

See all packs

Research packs

Incretin peptides: evidence review

A structured review of the published literature on GLP-1, GIP and glucagon receptor agonist peptides, from receptor pharmacology to registered clinical trials.

From £149

Market packs

New edition

UK and EU research peptide market report

How the research peptide market is structured: who supplies it, through which channels, at what prices, and how quality is (and isn't) evidenced.

From £349

Market packs

UK regulatory briefing: peptides

A plain-English briefing on how peptides are regulated in the UK: medicines classification, advertising rules, import, cosmetics and sport.

From £199

What's inside a pack

Every pack follows the same structure, so you always know where to find the method, the evidence and its limitations. This is the contents page from our market report.

Contents

UK and EU research peptide market report

  1. 1Summary of findingsThe ten things to know, each linked to its evidence3
  2. 2Method and sourcesWhat we looked at, how, and what we left out7
  3. 3Market structureChannels, business models and how money moves12
  4. 4Supplier landscapeSegmented and anonymised, with selection criteria24
  5. 5Pricing benchmarksRanges by compound and pack size, with sample dates38
  6. 6Quality and testingCertificates of analysis, third-party testing and red flags51
  7. 7Regulation and enforcementUK and EU position, recent actions62
  8. 8LimitationsWhere the data is thin and how to read it74
  9. 9References and change logFull citations and what changed since the last edition77

Page numbers refer to the current edition.

How it works

  1. Step 1

    Choose a pack

    Read the scope and contents of each pack. If you're not sure which one answers your question, ask us first.

  2. Step 2

    Confirm and pay

    Add packs to your basket, confirm you understand what you're buying, then pay by bank transfer.

  3. Step 3

    Download your pack

    Your download link arrives by email within minutes. Corrections to your edition are sent to you free of charge.

Who uses our packs

Our readers need an accurate, sourced picture of the field rather than marketing.

Investors and founders
Due diligence on a therapeutic area, a market or a competitor set.
Analysts and consultants
A referenced starting point that saves weeks of desk research.
Compliance and regulatory teams
A clear view of how products are classified and what enforcement looks like.
Researchers and students
Structured literature reviews with every source ready to export.
Journalists
Background on a fast-moving field, with the evidence and its limits stated.
Businesses in the sector
Market structure, pricing and regulatory context for planning.

How we research

Every factual claim in a Richmont pack is referenced to its source. We grade the strength of evidence, say plainly where it is weak, and separate what studies found from what is merely claimed. Market figures come with their method and date, so you can judge them yourself.

Sources we use

  • Peer-reviewed journals and indexed databases
  • Clinical trial registries, including ClinicalTrials.gov, ISRCTN and the EU Clinical Trials Register
  • Regulator publications from the MHRA, EMA and FDA
  • Company filings, public pricing and published market data
  • The World Anti-Doping Agency prohibited list

Standards we hold to

  • No supplier pays to be included, ranked or mentioned
  • Each edition is dated and carries a change log
  • Errors are corrected and every buyer of that edition is notified
  • We don't reproduce copyrighted papers; we summarise and cite them

Questions

Do you sell peptides?

No. Richmont sells research and market information only. We do not manufacture, sell, supply, source or broker any peptide or other substance, and we can't put you in touch with anyone who does.

Will a pack tell me how to use a peptide?

No. Our packs contain no dosing, administration or usage guidance for people or animals. Where studies report doses, we describe the study design, not instructions.

Is this medical advice?

No. Nothing we publish is medical advice. If you have a health question, speak to a GP, pharmacist or other registered healthcare professional.

Who writes the packs?

Packs are researched and written by Richmont's analysts and reviewed before release. Each pack names its authors, reviewers and review date.

How do I receive my pack?

As soon as your payment is confirmed, your downloads appear on your order page and we email you the links. Links stay active for 30 days.

Can I get a refund?

Because packs are digital and supplied immediately, the 14-day cancellation right ends once your download is made available, and you agree to this before paying. If a pack is faulty or not as described, you're entitled to a repair, replacement or refund. See our cancellations and refunds page for details.

Can I share a pack with my team?

Choose a team or company licence when you buy. A single-user licence covers one named person. For institutions or larger teams, contact us.

Do suppliers pay to be featured?

No. We don't accept payment, free products or commission from any supplier. Our market reports anonymise suppliers and explain how they were selected.

Get in touch

Questions about a pack, team licences, custom research or corrections. We reply within two working days.

Or email hello@richmont-consultants.co.uk

We'll use these details only to reply to your message. Read our privacy notice

Your basket

Your basket is empty.

Browse packs